Personal information

Activities

Employment (2)

Sun Yat-sen University Cancer Center: Guangzhou, CN

2020-08-03 to present (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Lanqing Huo

Peking Union Medical College Hospital: Dongcheng-qu, Beijing, CN

2018-01-01 to 2019-12-31 | MD (Department of Obstetrics and Gynecology)
Employment
Source: Self-asserted source
Lanqing Huo

Education and qualifications (2)

Tsinghua University: Beijing, Beijing, CN

Education
Source: Self-asserted source
Lanqing Huo

Chinese Academy of Medical Sciences and Peking Union Medical College: Beijing, Beijing, CN

MD
Education
Source: Self-asserted source
Lanqing Huo

Works (11)

RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer

Cell Death & Disease
2025-02-25 | Journal article
Contributors: Lanqing Huo; Xiaodan Huang; Ying Wang; Yi Ouyang; Xueping Zheng; Yingyi Ouyang; Xinping Cao; Kai Chen; Denghui Wei; Yuanzhong Wu et al.
Source: check_circle
Crossref

Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.

Cell death and differentiation
2023-11-25 | Journal article
Contributors: Xiao-Dan Huang; Huo L; Xiao B; Ouyang Y; Chen F; Li J; Zheng X; Wei D; Yuanzhong Wu; Zhang R et al.
Source: Self-asserted source
Lanqing Huo

Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.

Radiation oncology (London, England)
2023-09-26 | Journal article
Contributors: Li J; Wang Y; Huo L; Huang X; Shi L; Huang L; Chen K; Cao X
Source: Self-asserted source
Lanqing Huo

A pilot trial of consolidation bevacizumab after hypo-fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non-squamous non-small-cell lung cancer.

Cancer medicine
2023-08-03 | Journal article
Contributors: Huo L; Chu C; Jiang X; Zheng S; Zhang P; Zhou R; Chen N; Guo J; Qiu B; Hui Liu
Source: Self-asserted source
Lanqing Huo

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.

Therapeutic advances in medical oncology
2023-04-01 | Journal article
Contributors: Huang XD; Huo LQ; Luo YS; Chen K; Li JY; Shi L; Huang L; Cao XP; Ou-Yang Y; Chen FP
Source: Self-asserted source
Lanqing Huo

A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy.

Journal of inflammation research
2022-12-29 | Journal article
Contributors: Deyao Zhang; Huo L; Yang-Xun Pan; Yang Z; Zeng H; Wang X; Jinbin Chen; Wang J; Yaojun Zhang; Zhou Z et al.
Source: Self-asserted source
Lanqing Huo

Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.

Cell research
2022-10-24 | Journal article
Contributors: Gao Y; Zheng X; Chang B; Lin Y; Xiao-Dan Huang; Wang W; Ding S; Zhan W; Wang S; Xiao B et al.
Source: Self-asserted source
Lanqing Huo

Incidence, mortality, and survival analyses of patients with thymic lymphoma.

Frontiers in oncology
2022-09-14 | Journal article
Contributors: Wang L; Wang Z; Huo L; Zhao A
Source: Self-asserted source
Lanqing Huo

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.

Frontiers in oncology
2020-05-14 | Journal article
Contributors: Huo L; Wang D; Wang W; Cao D; Yang J; Wu M; Yang J; Xiang Y
Source: Self-asserted source
Lanqing Huo

Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis

Journal of Gynecologic Oncology
2019 | Journal article
Part of ISSN: 2005-0380
Part of ISSN: 2005-0399
Source: Self-asserted source
Lanqing Huo
grade
Preferred source (of 2)‎

Oncological Outcomes and Safety of Ovarian Preservation for Early Stage Adenocarcinoma of Cervix: A Systematic Review and Meta-Analysis

Frontiers in Oncology
2019-08-14 | Journal article
Part of ISSN: 2234-943X
Source: Self-asserted source
Lanqing Huo